ArticleInternational journal of molecular sciences2023

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.

Tianqi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.